SwePub
Sök i LIBRIS databas

  Extended search

id:"swepub:oai:DiVA.org:uu-351621"
 

Search: id:"swepub:oai:DiVA.org:uu-351621" > Systemic therapy of...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist
  • Sparber-Sauer, MonikaKlinikum Stuttgart Olgahosp, Stuttgart Canc Ctr, Zentrum Kinder Jugend & Frauenmed, Pediat Oncol Hematol & Immunol 5, Stuttgart, Germany. (author)

Systemic therapy of aggressive fibromatosis in children and adolescents : Report of the Cooperative Weichteilsarkom Studiengruppe (CWS)

  • Article/chapterEnglish2018

Publisher, publication year, extent ...

  • 2018-01-05
  • Wiley,2018
  • printrdacarrier

Numbers

  • LIBRIS-ID:oai:DiVA.org:uu-351621
  • https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-351621URI
  • https://doi.org/10.1002/pbc.26943DOI

Supplementary language notes

  • Language:English
  • Summary in:English

Part of subdatabase

Classification

  • Subject category:ref swepub-contenttype
  • Subject category:art swepub-publicationtype

Notes

  • BackgroundTreatment algorithms for patients with aggressive fibromatosis (AF) are challenging. There are limited data available about the use of systemic therapy (ST) in pediatric patients with AF.MethodsPatient-, tumor-, and treatment-related factors of 90 children and adolescents with AF treated on multiple prospective trials of the Cooperative Weichteilsarkom Studiengruppe (1981-2015) were analyzed with focus on response and outcome of ST.ResultsMedian age was 9.48 years (0.02-18.05). Primary resection was performed in 54 patients and ST was administered in 29 of 54 patients because of disease progression or relapse. In 35 patients, ST was the initial treatment modality. A secondary resection was performed in 21 of 35 patients after ST. A total of 64 patients received ST, mainly methotrexate and vinblastine (40%) with a median duration of 380 days. The most frequent radiological response to ST was stable disease at 3 months (39%) and partial response at 6 months (53%). Radiotherapy was administered to 15 of 90 patients. One patient remained on observation only. The 5-year overall survival was 100% and the 5-year event-free survival (EFS) was 44%. Patients who had a primary resection showed a 5-year EFS of 35% versus 59% in patients who had received primary ST (P=0.08). Functional deficiencies as long-term sequelae following resection occurred in 11 patients. At a median follow-up of 5.05 years (0.25-14.88), complete remission was achieved in 51 patients and partial remission in 28 patients.ConclusionsST seems appropriate if a primary complete resection is not feasible and at relapse/progression after resection.

Subject headings and genre

Added entries (persons, corporate bodies, meetings, titles ...)

  • Seitz, GuidoUniv Childrens Hosp Marburg, Dept Pediat Surg, Marburg, Germany. (author)
  • von Kalle, TheklaKlinikum Stuttgart Olgahosp, Inst Radiol, Zentrum Kinder Jugend & Frauenmed, Stuttgart, Germany. (author)
  • Vokuhl, ChristianUniv Kiel, Inst Paidopathol, Kiel, Germany. (author)
  • Leuschner, IvoUniv Kiel, Inst Paidopathol, Kiel, Germany. (author)
  • Scheer, MonikaKlinikum Stuttgart Olgahosp, Stuttgart Canc Ctr, Zentrum Kinder Jugend & Frauenmed, Pediat Oncol Hematol & Immunol 5, Stuttgart, Germany. (author)
  • Muenter, MarcKlinikum Stuttgart, Inst Radiotherapy, Stuttgart, Germany. (author)
  • Ljungman, Gustaf,1958-Uppsala universitet,Barnneurologi/Barnonkologi(Swepub:uu)gustaflm (author)
  • Bielack, Stefan S.Klinikum Stuttgart Olgahosp, Stuttgart Canc Ctr, Zentrum Kinder Jugend & Frauenmed, Pediat Oncol Hematol & Immunol 5, Stuttgart, Germany.;Univ Munster, Dept Pediat Hematol & Oncol, Munster, Germany. (author)
  • Niggli, FelixUniv Childrens Hosp Zurich, Dept Pediat Oncol, Zurich, Switzerland. (author)
  • Ladenstein, RuthSt Anna Childrens Hosp, Dept Pediat Oncol, Vienna, Austria. (author)
  • Klingebiel, ThomasGoethe Univ Frankfurt, Hosp Children & Adolescents, Frankfurt, Germany. (author)
  • Fuchs, JoergUniv Childrens Hosp, Dept Pediat Surg & Urol, Tubingen, Germany. (author)
  • Koscielniak, EwaKlinikum Stuttgart Olgahosp, Stuttgart Canc Ctr, Zentrum Kinder Jugend & Frauenmed, Pediat Oncol Hematol & Immunol 5, Stuttgart, Germany.;Univ Childrens Hosp, Dept Pediat Hematol & Oncol, Tubingen, Germany. (author)
  • Klinikum Stuttgart Olgahosp, Stuttgart Canc Ctr, Zentrum Kinder Jugend & Frauenmed, Pediat Oncol Hematol & Immunol 5, Stuttgart, Germany.Univ Childrens Hosp Marburg, Dept Pediat Surg, Marburg, Germany. (creator_code:org_t)

Related titles

  • In:Pediatric Blood & Cancer: Wiley65:51545-50091545-5017

Internet link

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view